Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-22T12:01:37.514Z Has data issue: false hasContentIssue false

Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression

Published online by Cambridge University Press:  05 December 2024

Emma S. Høgsted
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
Vincent Beliveau
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark Department of Neurology, Medical University of Innsbruck, Austria
Brice Ozenne
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark Department of Public Health, Section of Biostatistics, University of Copenhagen, Denmark
Martin K. Madsen
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
Claus Svarer
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
Vibeke H. Dam
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
Annette Johansen
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
Patrick Fisher
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark Department of Drug Design and Pharmacology, University of Copenhagen, Denmark
Gitte M. Knudsen
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark Department of Clinical Medicine, University of Copenhagen, Denmark
Vibe G. Frokjaer
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark Department of Clinical Medicine, University of Copenhagen, Denmark Mental Health Center Copenhagen, Copenhagen University Hospital – Mental Health Services CPH, Copenhagen, Denmark
Anjali Sankar*
Affiliation:
Neurobiology Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
*
Correspondence: Anjali Sankar. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Background

Using [18F]altanserin, a serotonin 2A receptor (5-HT2AR) antagonist Positron Emission Tomography (PET) tracer, a positive association between cortical 5-HT2AR binding and the inward-directed facets of neuroticism has been demonstrated in healthy individuals. Psilocybin, a 5-HT2AR agonist, shows promise for the treatment of depression, reducing neuroticism and mood symptoms potentially via hypothalamic-pituitary-adrenal (HPA) modulation. 5-HT2AR and neuroticism are both modulated by HPA axis function.

Aims

In this study, we examined whether the association between 5-HT2AR binding and the inward facets of neuroticism can be replicated in an independent healthy cohort using the new 5-HT2AR agonist tracer [11C]Cimbi-36, and if their association is moderated by cortisol awakening response (CAR), an index of HPA axis function. If so, this could advance mechanistic insights into interventions that target the 5-HT2AR and reduce neuroticism.

Method

Eighty healthy volunteers underwent [11C]Cimbi-36 PET scans and completed the NEO personality inventory (NEO-PI-R) for the assessment of neuroticism. Salivary samples were available for determination of CAR in 70 of the participants. Using linear latent variable models, we evaluated the association between 5-HT2AR binding and inward facets of neuroticism, namely depression, anxiety, self-consciousness and vulnerability to stress, and whether CAR moderated this association.

Results

The study confirms the positive association between 5-HT2AR binding and the inward facets of neuroticism (β = 0.01, 95% CI = [0.0005: 0.02], P = 0.04), and this association is independent of CAR (P = 0.33).

Conclusions

The findings prompt consideration of whether novel interventions such as psilocybin that actively targets 5-HT2AR and causes changes in personality could be particularly beneficial if implemented as a targeted approach based on neuroticism profiles.

Type
Original Article
Copyright
Copyright © The Author(s), 2024. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

The personality trait of neuroticism shapes individuals’ reactions to stressful situationsReference Bolger and Schilling1 and is a risk factor for the onset of psychiatric illnesses, especially major depressive disorder (MDD).Reference Zinbarg, Mineka, Bobova, Craske, Vrshek-Schallhorn and Griffith2 Research into the neurobiology of MDD strongly supports the role of the serotonin 2A receptor (5HT2AR) system in the disorder's pathophysiologyReference Mintun, Sheline, Moerlein, Vlassenko, Huang and Snyder3Reference Steinberg, Underwood, Bakalian, Kassir, Mann and Arango6 and in behavioural phenotypes that are risk factors for depression including stress sensitivity,Reference Murnane7 emotion processing,Reference Fisher, Price, Meltzer, Moses-Kolko, Becker and Berga8 and personality traits such as pessimism (or negative styles of thinking) and neuroticism.Reference Bhagwagar, Hinz, Taylor, Fancy, Cowen and Grasby9,Reference Frokjaer, Mortensen, Nielsen, Haugbol, Pinborg and Adams10 In one of the largest reported serotonin receptor imaging studies in healthy controls (n = 83), an association was shown between 5-HT2AR binding and neuroticism using the [18F]altanserin tracer.Reference Frokjaer, Mortensen, Nielsen, Haugbol, Pinborg and Adams10 Subsequently, it was also shown that this link between serotonergic function and neuroticism was stronger in individuals with a high familial risk of developing depression, relative to individuals with a low familial risk.Reference Frokjaer, Vinberg, Erritzoe, Baaré, Holst and El11 Interestingly, in these reports, the facets or dimensions of neuroticism that were closely linked to 5-HT2AR binding were those that are directed ‘inwards’, namely depression, anxiety, self-consciousness and vulnerability to stress, as opposed to the impulsivity and angry hostility facets which are directed ‘outward’ when faced with frustration.Reference Frokjaer, Vinberg, Erritzoe, Baaré, Holst and El11 Thus, the inward-directed facets of neuroticism may be particularly sensitive to modulation by 5-HT2AR function.

In the present study, we examined whether there exists an association between 5-HT2AR and the inward facets of neuroticism in healthy individuals when imaged with a new 5-HT2AR agonist Positron Emission Tomography (PET) tracer [11C]Cimbi-36. If indeed the previously observed association between cortical 5-HT2AR binding and inward neuroticism represents a generalisable phenomenon across different PET tracers, scanner conditions and populations, then this could point to a possible mechanism by which drugs that target the 5-HT2AR change personality structures and alleviate depressive symptoms or other psychopathology. For instance, psilocybin exerts its psychoactive effect as an agonist of the 5-HT2ARReference Madsen, Fisher, Burmester, Dyssegaard, Stenbæk and Kristiansen12 and is considered a promising drug for the treatment of MDD. Psilocybin's stimulation of the 5-HT2AR appears to significantly reduce neuroticism and leads to alterations in mood, perception and consciousness.Reference Erritzoe, Roseman, Nour, Maclean, Kaelen and Nutt13 It is posited that the hypothalamic-pituitary-adrenal (HPA) axis function may play a key role in psilocybin's salutary effects on mood.Reference Mason, Szabo, Kuypers, Mallaroni, De La Torre Fornell and Reckweg14 A method to characterise the HPA axis function is by measuring the cortisol awakening response (CAR). CAR indexes the increase in cortisol levels that occurs within the first hour upon morning awakening and is posited to be a marker of naturally occurring physiological (stimulated) cortisol response.Reference Stalder, Lupien, Kudielka, Adam, Pruessner and Wüst15 The function of 5-HT2AR and neuroticism are both closely related to cortisol dynamics. Evidence from preclinical studies indicates that 5-HT2AR is upregulated by various stressorsReference Murnane7 and stimulates the production of corticotropin-releasing factor which promotes the production of cortisol.Reference Van De Kar, Javed, Zhang, Serres, Raap and Gray16 Likewise, individuals with high neuroticism typically exhibit heightened stress reactivity,Reference Gunthert, Cohen and Armeli17,Reference Dunkley, Mandel and Ma18 and higher cortisol secretion.Reference Garcia-Banda, Chellew, Fornes, Perez, Servera and Evans19 Together, these studies suggest that 5-HT2AR and neuroticism are closely linked to cortisol dynamics and that their association may be influenced by variations in cortisol dynamics. Therefore, we include cortisol markers to examine if the association between 5-HT2AR binding and the inward facets of neuroticism is dependent on cortisol dynamics in terms of CAR. We hypothesise that there is a significant association between 5-HT2AR binding and inward facets of neuroticism, and furthermore that this association is moderated by CAR. Together, the study findings may advance mechanistic understanding of how interventions that target the 5-HT2AR reduce neuroticism and mood symptoms.

Method

Participants

We identified individuals within the Center for Integrated Molecular Brain Imaging (CIMBI) databaseReference Knudsen, Jensen, Erritzoe, WFC, Ettrup and Fisher20 that met the following criteria: (a) completed a baseline [11C]CIMBI-36 scan, (b) completed an assessment of neuroticism using the NEO-Personality Inventory-Revised (NEO-PI-R),Reference Costa and McCrae21 and (c) were healthy including no lifetime history of neurological and psychiatric disorders. Eighty healthy individuals met the above criteria and were included in the present study. Seventy of these individuals additionally provided salivary samples for the determination of CAR.

The included individuals had participated in neuroimaging studies at the Neurobiology Research Unit, Copenhagen University Hospital (Rigshospitalet) from 2012 to 2021. Written informed consent was obtained from all participants before their inclusion in the respective studies. The individual study protocols were approved by the Ethics Committee of Copenhagen and Frederiksberg, Denmark (protocol number: VEK H-4-2012-105, VEK (KF)01-2006-20, VEK H-15004506 and VEK H-16026898).

Procedures

Magnetic resonance imaging (MRI)

MRI scans were performed on a 3 T Verio scanner (n = 30) or a 3 T Prisma scanner (n = 50) using the following parameters: Verio/Prisma: repetition time = 1900 ms, echo time = 2.32/2.58 ms, inversion time = 900 ms, flip angle = 9°, in-plane matrix = 256 × 256, in-plane resolution = 0.9 × 0.9 mm, 224 slices and a slice thickness of 0.9 mm, no gap. The images were segmented using Voxel Based Morphometry (VBM8) implemented in Statistical Parametric Mapping (SPM8) (https://www.fil.ion.ucl.ac.uk/spm/software/spm12/)Reference Ashburner, Barnes, Chen, Daunizeau, Flandin and Friston22 to mask grey matter in the subsequent extraction of tissue time-activity curves (TACs).

PET data acquisition

Procedures for PET acquisition have been described in detail elsewhere.Reference Ettrup, Svarer, Mcmahon, Da Cunha-Bang, Lehel and Møller23 Briefly, scans were conducted using a high-resolution research tomography (HRRT) PET scanner with parameters: matrix = 256 × 256 × 207 voxels, voxel size = 1.22 × 1.22 × 1.22 mm. All participants underwent a transmission scan using the built-in source for attenuation and scatter correction followed by a 120 min emission scan which started at the time of the intravenous bolus injection of [11C]Cimbi-36 (mean injected activity: 499 ± 109 MBq; injected mass of Cimbi-36: 0.72 ± 0.44 μg). [11C]Cimbi-36 scan data were reconstructed into 45 dynamic frames (6 × 10 s, 6 × 20 s, 6 × 60 s, 8 × 120 s and 19 × 300 s) using the methods described previously.Reference Keller, Svarer and Sibomana24

PET processing and quantification

PET processing was performed as previously described.Reference Ettrup, Svarer, Mcmahon, Da Cunha-Bang, Lehel and Møller23 Briefly, motion-corrected PET images were co-registered with the participants’ T1-weighted image using SPM8. Automatic delineation of regions of interest was performed using PVElab (MATrix LABoratory (MATLAB), Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark).Reference Svarer, Madsen, Hasselbalch, Pinborg, Haugbøl and Frøkjær25 A global neocortical region of interest (ROI) was defined as a volume-weighted mean of the following cortical ROIs: orbitofrontal cortex, superior, middle and inferior frontal gyrus; superior, middle and inferior temporal gyrus, sensorimotor cortex, parietal cortex and occipital cortex. A composite neocortex ROI was used because the signal is highly correlated between the neocortical regions.Reference Spies, Nasser, Ozenne, Jensen, Knudsen and Fisher26

Kinetic modelling using the simplified reference tissue model (SRTM)Reference Lammertsma and Hume27 with the cerebellum (excluding vermis) as the reference tissue was performed with in-house MATLAB scripts. The calculated non-displaceable binding potential (BP ND) served as the outcome measure for quantifying 5-HT2A binding. BP ND is defined as:

$${BP}_{{\rm ND}} = \displaystyle{{V_T-V_{{\rm ND}}} \over {V_{{\rm ND}}}} $$

where V T and V ND are the distribution volumes in the ROI and reference region (cerebellum), respectively.

In addition to extracting mean 5-HT2AR BP ND values in the neocortex using the methods described above, we generated vertex-wise (surface) cortical 5-HT2AR BP ND maps to visualise the distribution of cortical 5-HT2AR BP ND associated with the inward facets of neuroticism. The vertex-wise cortical 5-HT2AR BP ND maps were generated using the PETSurferReference Greve, Svarer, Fisher, Feng, Hansen and Baare28 processing stream in FreeSurfer (version 7.3.2; see http://surfer.nmr.mgh.harvard.edu),Reference Fischl29 as described previously.Reference Beliveau, Ganz, Feng, Ozenne, Højgaard and Fisher30 FastSurfer (version 2.0.1; see https://doi.org/10.1016/j.neuroimage.2020.117012) was used in place of FreeSurfer to process the structural images (recon-all). Briefly, PET–MRI co-registration was estimated using linear registration between the structural MRI and the time-weighted average of the dynamic PET images. Cortical vertex-wise TACs were obtained by resampling the dynamic PET data onto the common fsaverage surface space registration.Reference Postelnicu, Zollei and Fischl31 Cortical TACs were surface smoothed by 10 mm full-width at half-maximum.

Kinetic modelling of the parametric BP ND was performed using the Multilinear Reference Tissue Model 2 (MRTM2)Reference Ichise, Liow, Lu, Takano, Model and Toyama32 with cerebellar grey matter as the reference region. Cerebellar grey matter masks were obtained by taking the intersection of the cerebellar grey matter segmentation defined by FastSurfer and a cerebellar grey matter segmentation, excluding vermis, derived using SUIT 3.1 (_python3, Brain and Mind Institute, University of Western Ontario, London, UK, and Ontario, Canada).Reference Diedrichsen33 The reference region washout rate (k 2′) was computed using MRTMReference Ichise, Ballinger, Golan, Vines, Luong and Tsai34 and a noise-free high-binding TAC was obtained from a surface-weighted average of the neocortical regions for this purpose.

Neuroticism

Participants completed the Danish version of the 240-item NEO-Personality Inventory-Revised (NEO-PI-R); this version has been normed in a sample of 600 individuals.Reference Skovdahl, Mortensen and Schiøtz35 The NEO-PI-R is a self-reported personality questionnaire that evaluates the broad personality traits of neuroticism, extraversion, openness, agreeableness and conscientiousness. Each trait is made up of six constituent facets which for the neuroticism trait include anxiety, depression, self-consciousness, vulnerability, angry hostility and impulsiveness. Each facet score is derived by summing the scores of six constituent items. The outcome measures of neuroticism for this study were the facets of anxiety, depression, self-consciousness and vulnerability to stress, as these facets have previously been shown to be associated with 5-HT2AR binding.Reference Frokjaer, Vinberg, Erritzoe, Baaré, Holst and El11

Cortisol awakening response

For the assessment of CAR, participants were instructed to collect saliva samples at home immediately after awakening and after 15, 30, 45 and 60 min. Saliva samples were collected in Salivette tubes (Sarstedt, Neubringen, Germany) by chewing a swab until it was completely saturated with saliva. Participants were instructed to avoid food intake, drinking, brushing their teeth and smoking during the first hour after waking up. If the first saliva sample was collected more than 10 min after awakening, the data-set was not included in our analyses. The participants noted whether the CAR samples were collected on a work day, study day or weekend/day off, and also noted the time of awakening and collection of the saliva sample. The saliva samples collected at home were stored in the refrigerator and returned to the laboratory the day after the completion of sampling, and if collected during the weekend, a maximum of 3 days after collection. The samples were subsequently stored at −80°C until analysis. Samples were shipped on dry ice to an external laboratory, and cortisol concentrations were analysed in four different batches across the collection period (i.e. 2012–2021) to minimise laboratory-dependent noise. The analysis of the first batch (37% of the total sample) was performed using the electroluminescence immunoassay (ECLIA) method on Modular Analytics E170 equipment (Roche, Mannheim, Germany), whereas the three remaining batches were analysed using the chemiluminescence immunoassay (CLIA) method on the IDS-iSYS automatic analyser (IDS plc, Boldon, UK). The intra- and inter-assay variations of both immunoassay methods were less than 15%. We also had internal saliva samples that were run with each batch for quality control.Reference Høgsted, Borgsted, Dam, Nasser, Rye Jørgensen and Ozenne36 The CAR measurements were computed as the area under the curve (AUC) with respect to the increase from baseline at waking (AUCi). The AUCi captures change over time and is thereby an index of reactivity of the HPA axis.Reference Fekedulegn, Andrew, Burchfiel, Violanti, Hartley and Charles37 There was no significant difference in AUCi values among the collection days (P = 0.14).

Statistical analyses

Analyses of demographic, clinical, scanner and radiotracer data

Analyses were conducted in R (version 4.3.12022.2.0)Reference R Core Team38 using RStudio. Group differences between males and females in continuous (age, weight-adjusted [11C]Cimbi-36 injected mass (μg/kg)) and categorical variables (magnetic resonance scanner type) were evaluated using Mann–Whitney U-tests and Fisher's exact tests, respectively. All results were considered significant at P < 0.05.

Analysis of the association between neocortical 5-HT2AR BP ND and neuroticism

We applied a linear latent variable model (LVM) using the lava package (version 7.2.1)Reference Holst and Budtz-Jørgensen39 implemented in R to first examine the association between 5-HT2AR binding in the neocortex and the inward-directed facets of neuroticism in 80 healthy individuals. LVM is used to model the association between neuroticism and PET with a single parameter via a latent variable.

This latent variable, denoted Inward-NeuroticismLV captures the shared signal between facets and can be seen as a weighted average of the facets where the weights are estimated via maximum likelihood. The PET outcome variable was log-transformed 5-HT2AR BP ND in the neocortex, and the neuroticism outcome variable was a latent variable (termed Inward-NeuroticismLV) representing the inward-directed facets of neuroticism, namely anxiety, depression, self-consciousness and vulnerability. Inward-NeuroticismLV was adjusted for age and gender, while neocortical 5-HT2AR BP ND values were adjusted for age, gender and magnetic resonance scanner type. The association between 5-HT2AR BP ND and the Inward-NeuroticismLV is described in terms of regression coefficients (‘parameter estimate’). The 5-HT2AR BP ND vertex maps were input into the same LVM model to aid the visualisation of this association at each cortical vertex. The parameter estimate and P-value maps were created using the oro.nifti packageReference Whitcher, Schmid and Thornton40 in R, and visualised using FreeSurfer.Reference Fischl29

A sensitivity analysis using structural equation modelling examined the association between 5-HT2AR BP ND and the inward facets of neuroticism when the latter was calculated as the sum of its constituent traits (rather than as a latent variable). As in the LVM, neuroticism was adjusted for age and gender and 5-HT2AR BP ND was adjusted for age, gender and magnetic resonance scanner type.

CAR as a moderator of the association between neocortical 5-HT2AR BP ND and neuroticism

In individuals with data on CAR, secondary analysis with LVM was performed to determine if cortisol dynamics, as measured with CAR, moderated the association between 5-HT2AR BP ND and Inward-NeuroticismLV. To perform this moderation analysis with LVM, CAR values were split into three equally sized categories.

Gender as a moderator of the association between neocortical 5-HT2AR BP ND and neuroticism

Lastly, an exploratory analysis using an LVM investigated whether gender moderated the association between 5-HT2AR BP ND and Inward-NeuroticismLV. Gender differences in neuroticism have been repeatedly observed, with females reporting higher levels of this trait relative to males.Reference Schmitt, Realo, Voracek and Allik41,Reference South, Jarnecke and Vize42 Although 5HT2AR binding has not consistently been shown to differ by gender,Reference Soloff, Price, Mason, Becker and Meltzer43Reference Adams, Pinborg, Svarer, Hasselbalch, Holm and Haugbøl45 5HT2AR binding has been found to be positively associated with endogenous estradiol levels.Reference Frokjaer, Erritzoe, Juul, Nielsen, Holst and Svarer46 The evidence for the effect of gender on neuroticism and potentially on 5-HT2AR BP ND motivated this exploratory analysis.

For all the above-mentioned LVMs, the relevance of additional model paths was assessed using score tests (via the modelsearch function within the lava package). The path with the lowest P-value was added to the model if the adjusted P-value was below 0.05. A Bonferroni adjustment was used over all possible paths to control the family-wise error rate at 0.05. This procedure was repeated until no new model paths were supported.

Results

Demographic, clinical, scanner and radiotracer information

The sample included 80 individuals aged 18–58 years (median age: 27.3 years; inter-quartile range: 8.04 years). Our sample was well-balanced with 55% males and 45% females, and there were no significant differences in age (P = 0.20), weight-adjusted [11C]Cimbi-36 injected mass (P = 0.38) or MR scanner type distribution (P = 0.50) between males and females. CAR AUCi was calculated for 70 of the 80 individuals included in the study (median AUCi: 58.84; inter-quartile range: 248.18). AUCi was not calculated for the remaining 10 individuals because of factors such as failure to provide saliva samples (n = 2), missing data points for the calculation of AUCi (n = 5), incorrect or missing collection time (n = 2) and inadequate saliva volume for AUCi calculations (n = 1). Additional demographics and radiotracer information for healthy individuals are detailed in Table 1.

Table 1 Demographic, clinical, scanner and radiotracer information

IQR, inter-quartile range; MRI, magnetic resonance imaging; CAR, cortisol awakening response; AUCi, area under the curve with respect to increase from baseline at awakening.

The estimate loadings (regression coefficients) of the latent variable (summarised by the Inward-NeuroticismLV) onto its constituent facets ranged from 0.80 to 1.52, all P < 0.001, indicating that all facets significantly correlated with the latent variable. The constituent facet of depression loaded the most (β = 1.52) and self-consciousness the least (β = 0.80) on the Inward-NeuroticismLV, as visualised in Fig. 1. The first LVM-based model showed a positive relation between neocortex 5-HT2AR BP ND and Inward-NeuroticismLV across all participants (β = 0.01, 95% CI = 0.0005: 0.02, P = 0.04; Fig. 1). Figure 2 is a visualisation of this association using vertex-wise cortical 5-HT2AR BP ND maps. Additionally, the LVM showed a negative association between 5-HT2AR BP ND and age (β = −0.012, 95% CI = −0.008: −0.016, P < 0.001). The sensitivity analysis also showed a significant positive association between 5-HT2AR BP ND and the total inward neuroticism score (P = 0.04).

Figure 1 Latent variable model to estimate the association between 5-HT2AR binding and the inward facets of neuroticism.

This figure shows the estimated latent variable model of the association between 5-HT2AR binding and the inward facets of neuroticism. The ellipse represents the latent variable capturing Inward-NeuroticismLV. Circular dashed lines represent error estimates included in the model. λ represents the loading of a given neuroticism sub-facet estimate onto its respective latent variable. Both Inward-NeuroticismLV and neocortex BP ND were adjusted for age and gender, and neocortex BP ND was additionally adjusted for magnetic resonance (MR) scanner type. Self-cons, self-consciousness; BP ND, non-displaceable binding potential.

Figure 2 Visualisation of the distribution of cortical 5-HT2AR and associations with the inward facets of neuroticism. (a) The regional association between 5-HT2AR binding with the latent estimates of inward neuroticism in the cortex. The maps are thresholded at P = 0.05. The colour-bar represents the range of estimate values. (b) The distribution of 5-HT2AR in the cortex (reproduced with permission from Beliveau et alReference Greve, Svarer, Fisher, Feng, Hansen and Baare28).

We did not find evidence that CAR moderated the association between 5-HT2AR BP ND and Inward-NeuroticismLV (P = 0.33). There was also no evidence for a moderating effect of gender on the association between 5-HT2AR BP ND and Inward-NeuroticismLV (P = 0.99).

Discussion

This study replicates previously reported findings of an association between brain 5-HT2AR and the inward facets of neuroticism in healthy individuals. Using a latent variable model framework, we showed a positive association between neocortical 5-HT2AR binding, measured using the [11C]Cimbi-36 PET tracer, and the inward facets of neuroticism, namely vulnerability, depression, self-consciousness and anxiety. Furthermore, there was no evidence that this association was moderated by cortisol dynamics or gender.

Using a 5-HT2AR PET antagonist tracer [18F]altanserin, a significant positive association between 5-HT2AR binding and the inward facets of neuroticism was previously found in healthy individuals,Reference Frokjaer, Mortensen, Nielsen, Haugbol, Pinborg and Adams10 and this association was stronger in individuals with a high familial risk for depression relative to those with low familial risk, suggesting a link to risk brain architecture.Reference Frokjaer, Vinberg, Erritzoe, Baaré, Holst and El11 In further support of this association, a longitudinal study in healthy individuals found that those with the phenotype for high inward neuroticism and high 5-HT2AR binding have an elevated risk of developing depression in the future.Reference Sankar, Ziersen, Ozenne, Dam, Beaman and Kessing47 Treatment with antidepressant drugs downregulates 5-HT2AR, suggesting that 5-HT2A upregulation is a compensatory mechanism for serotonin deficiency.Reference Muguruza, Miranda-Azpiazu, Díez-Alarcia, Morentin, González-Maeso and Callado48 To what extent genetic predisposition and environmental stress shape 5-HT2AR density is not well understood. However, in light of the non-significant findings with stress response (CAR), we speculate that the association between 5-HT2AR binding and the inward facets of neuroticism reflects a partly shared biological mechanism by which a genetic predisposition to 5-HT2AR availability may contribute to increased neuroticism even in the absence of environmental stressors.Reference Sankar, Ziersen, Ozenne, Dam, Beaman and Kessing47 Our study findings lend support to the use of novel interventions such as psilocybin which actively targets the 5-HT2AR and causes long-lasting changes in neuroticismReference Frokjaer, Mortensen, Nielsen, Haugbol, Pinborg and Adams10 for the treatment of depression.

Stress responses are intimately linked with serotonergic neurotransmission, and vulnerability to stress represents a feature of neuroticism. However, we did not detect a moderating effect of CAR on the association between serotonin function and neuroticism. This is the first study to examine the interplay between serotonin, neuroticism and CAR in the healthy brain, although previous work has examined the association of CAR separately with serotonin function and neuroticism. For instance, studies have previously found associations between CAR and several serotonergic markers, including negative associations of CAR with 5-HT4R binding,Reference Jakobsen, Fisher, Dyssegaard, Mcmahon, Holst and Lehel49 and positive associations of CAR with serotonin transporter binding.Reference Frokjaer, Erritzoe, Holst, Jensen, Rasmussen and Fisher50 In recent work, however, the association between CAR and serotonin transporter binding was not replicated.Reference Conradi, Svensson, Larsen and Frokjaer51 This may in part be because of differences in sample characteristics, as the latter study included predominantly young women relative to earlier studies,Reference Miller, Wright, Peterson, Kamarck, Anderson and Kirschbaum52 and calculated AUCi over 60 min after awakening relative to earlier studies that calculated AUCi over a 15 h time span.Reference Jakobsen, Fisher, Dyssegaard, Mcmahon, Holst and Lehel49 Likewise, the relation of neuroticism with cortisol has also been previously reported,Reference Puig-Perez, Almela, Pulopulos, Hidalgo and Salvador53 although less consistently when neuroticism was studied in relation to measures of cortisol change (i.e. CAR).Reference Garcia-Banda, Chellew, Fornes, Perez, Servera and Evans19,Reference Puig-Perez, Almela, Pulopulos, Hidalgo and Salvador53 To consider the role of differences in the quantification of cortisol response in the relation between neuroticism and cortisol, a study evaluated cortisol in three different ways (CAR, diurnal slope and total output) over multiple days, but did not find associations between cortisol dynamics and neuroticism for any of the measures.Reference Miller, Wright, Peterson, Kamarck, Anderson and Kirschbaum52 These studies highlight inconsistent findings on the relation of cortisol dynamics to 5-HT2AR binding and neuroticism in healthy individuals.

In the present study, we found no evidence that gender moderated the association between 5-HT2AR binding and the inward facets of neuroticism. However, we found a negative association between 5-HT2AR binding and age, replicating previously reported finding with the [18F]altanserin tracer.Reference EL, Price, Shah, Berga, Sereika and Fisher44,Reference Adams, Pinborg, Svarer, Hasselbalch, Holm and Haugbøl45,Reference Conradi, Svensson, Larsen and Frokjaer51 Evidence for gender differences in 5-HT2AR binding in healthy individuals in the literature has been inconclusive with reports of no significant differences between the genders,Reference Soloff, Price, Mason, Becker and Meltzer43Reference Adams, Pinborg, Svarer, Hasselbalch, Holm and Haugbøl45 as well as higher binding in males relative to females.Reference Soloff, Price, Mason, Becker and Meltzer43

Methodological inconsistencies, and, importantly, differences in tracers are often cited as reasons for the mixed findings in the PET literature,Reference Parsey and Mann54 and the replicability crisis in neuroscience is one of the main barriers to the translation of research findings into clinical practice. The current independent replication with the new agonist tracer [11C]Cimbi-36 provides strong support to the link between 5-HT2AR binding and inward-directed neuroticism in healthy adults and to interventions that target the 5-HT2AR system, such as psilocybin, in reducing neuroticism and alleviating mood symptoms.Reference Frokjaer, Mortensen, Nielsen, Haugbol, Pinborg and Adams10 The findings of the study, however, should be considered in the context of its limitations. 5-HT2AR is most abundantly found in the neocortex where the signal with the applied PET method is also best captured, and therefore we limited our investigation to neocortical 5-HT2AR binding and its association with the inward facets of neuroticism. We did not include individuals older than 60 years, therefore our results may not be generalisable to older populations. One of the reasons for the absence of a moderating effect of CAR on the association between 5-HT2AR and neuroticism in our study could be because variations in HPA dynamics may be difficult to capture in a healthy sample. HPA axis dysfunction has been shown to be present in severe or acute major depressive episodes rather than mild or atypical depression.Reference Miller, Wright, Peterson, Kamarck, Anderson and Kirschbaum52 Hence, HPA dynamics may have a distinct impact in relation to environmental stress such as stressful life events or the onset of a mood disorder, but might not be evident in a healthy sample,Reference Parsey and Mann54 in which case we would not expect to be able to detect any association with underlying brain architecture. Thus, further studies on the influence of cortisol dynamics on 5-HT2AR binding and neuroticism in a depressed sample, a high-risk sample or a sample that recently experienced stressful life events are warranted. The absence of a moderating effect of CAR on the association between 5-HT2AR and neuroticism in our study could also be because of our choice of cortisol measure. We aimed to characterise the HPA axis function using the CAR AUCi. While this measure serves as a relevant composite indicator of cortisol responses and has been previously demonstrated to relate to serotonergic brain architecture,Reference Jakobsen, Fisher, Dyssegaard, Mcmahon, Holst and Lehel49,Reference Frokjaer, Erritzoe, Holst, Jensen, Rasmussen and Fisher50 it does not encompass the full spectrum of dynamic parameters of cortisol release. Alternative metrics, such as total CAR, mean cortisol and peak cortisol levels, were not included in our analysis.

In conclusion, we provide robust and consistent evidence for the link between 5-HT2AR binding and the inward-directed personality facets of neuroticism. There was no evidence that cortisol dynamics moderated the association between 5-HT2AR binding and inward-directed neuroticism in healthy individuals. Further, the association persists across gender. The confirmatory positive association between 5-HT2AR binding and neuroticism prompts consideration of whether novel interventions such as psilocybin that actively targets 5-HT2AR and causes changes in personality could be particularly beneficial if implemented as a targeted approach based on neuroticism profiles.

Data availability

Because of the General Data Protection Regulation, the data that support the findings of this study are not readily available. Data in the CIMBI database can be accessed by application (http://www.cimbi.dk/db). The relevant code associated with the data availability is available upon reasonable request from the authors.

Author contributions

E.S.H. made substantial contributions to the curation and analysis of data, interpretation of study findings, drafting of the manuscript and revising it critically for intellectual content. V.B. substantially contributed towards the analysis of the data and revising the manuscript critically for intellectual content. B.O. provided statistical expertise for the analyses performed herein, and substantially contributed to the interpretation of findings, drafting of the manuscript and revising it critically for intellectual content. M.K.M., C.S., A.J., V.H.D., P.F. and G.M.K. substantially contributed to the interpretation of findings and critical revisions of the manuscript. V.G.F. and A.S. made substantial contributions to the conception and design of the study, curation and analysis of data, interpretation of findings and critical revisions of the manuscript.

Funding

The study was supported by the Lundbeck Foundation (grant ID: R279-2018-1145), the Research Council of Rigshospitalet (grant ID A6594) and the Danish Psychiatric Society.

Declaration of interest

G.M.K. has within the last 3 years served as a consultant for Onsero, Gilgamesh, Pure, Pangea and Sanos, and as a speaker for Abbvie, Angelini and H. Lundbeck. V.G.F. has served as a consultant for SAGE therapeutics, and as a lecturer for H. Lundbeck, Janssen-Cilag and Gedeon-Richther. V.H.D. has served as a lecturer for H. Lundbeck. M.K.M. has served as a lecturer for the Lundbeck Foundation and H. Lundbeck. All other authors declare no conflict of interest.

Footnotes

*

Joint last authors.

References

Bolger, N, Schilling, EA. Personality and the problems of everyday life: the role of neuroticism in exposure and reactivity to daily stressors. J Pers 1991; 59(3): 355–86.CrossRefGoogle ScholarPubMed
Zinbarg, RE, Mineka, S, Bobova, L, Craske, MG, Vrshek-Schallhorn, S, Griffith, JW, et al. Testing a hierarchical model of neuroticism and its cognitive facets: latent structure and prospective prediction of first onsets of anxiety and unipolar mood disorders during 3 years in late adolescence. Clin Psychol Sci 2016; 4(5): 805–24.CrossRefGoogle Scholar
Mintun, MA, Sheline, YI, Moerlein, SM, Vlassenko, AG, Huang, Y, Snyder, AZ. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F] altanserin positron emission tomography. Biol Psychiatry 2004; 55(3): 217–24.CrossRefGoogle ScholarPubMed
Akin, D, Manier, DH, Sanders-Bush, E, Shelton, RC. Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology 2004; 29(11): 2081–7.CrossRefGoogle ScholarPubMed
Sheline, YI, Mintun, MA, Barch, DM, Wilkins, C, Snyder, AZ, Moerlein, SM. Decreased hippocampal 5-HT2A receptor binding in older depressed patients using [18F] altanserin positron emission tomography. Neuropsychopharmacology 2004; 29(12): 2235–41.CrossRefGoogle ScholarPubMed
Steinberg, LJ, Underwood, MD, Bakalian, MJ, Kassir, SA, Mann, JJ, Arango, V. 5-HT1A receptor, 5-HT2A receptor and serotonin transporter binding in the human auditory cortex in depression. J Psychiatry Neurosci 2019; 44(5): 294302.CrossRefGoogle ScholarPubMed
Murnane, KS. Serotonin 2a receptors are a stress response system: implications for post-traumatic stress disorder. Behav Pharmacol 2019; 30(2 and 3): 151–62.CrossRefGoogle ScholarPubMed
Fisher, PM, Price, JC, Meltzer, CC, Moses-Kolko, EL, Becker, C, Berga, SL, et al. Medial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdala reactivity. Biol Mood Anxiety Disord 2011; 1(1): 111.CrossRefGoogle ScholarPubMed
Bhagwagar, Z, Hinz, R, Taylor, M, Fancy, S, Cowen, P, Grasby, P. Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [11C] MDL 100,907. Am J Psychiatry 2006; 163(9): 1580–7.CrossRefGoogle ScholarPubMed
Frokjaer, VG, Mortensen, EL, Nielsen, , Haugbol, S, Pinborg, LH, Adams, KH, et al. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry 2008; 63(6): 569–76.CrossRefGoogle ScholarPubMed
Frokjaer, VG, Vinberg, M, Erritzoe, D, Baaré, W, Holst, KK, El, M, et al. Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding. Neuropsychopharmacology 2010; 35(5): 1129–37.CrossRefGoogle ScholarPubMed
Madsen, MK, Fisher, PM, Burmester, D, Dyssegaard, A, Stenbæk, DS, Kristiansen, S, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology 2019; 44(7): 1328–34.CrossRefGoogle ScholarPubMed
Erritzoe, D, Roseman, L, Nour, M, Maclean, K, Kaelen, M, Nutt, D, et al. Effects of psilocybin therapy on personality structure. Acta Psychiatr Scand 2018; 138(5): 368–78.CrossRefGoogle Scholar
Mason, N, Szabo, A, Kuypers, K, Mallaroni, P, De La Torre Fornell, R, Reckweg, J, et al. Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: an experimental, placebo-controlled study. Brain Behav Immun 2023; 114: 299310.CrossRefGoogle ScholarPubMed
Stalder, T, Lupien, SJ, Kudielka, BM, Adam, EK, Pruessner, JC, Wüst, S, et al. Evaluation and update of the expert consensus guidelines for the assessment of the cortisol awakening response (CAR). Psychoneuroendocrinology 2022; 146: 105946.CrossRefGoogle ScholarPubMed
Van De Kar, LD, Javed, A, Zhang, Y, Serres, F, Raap, DK, Gray, TS. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 2001; 21(10): 3572–9.CrossRefGoogle ScholarPubMed
Gunthert, KC, Cohen, LH, Armeli, S. The role of neuroticism in daily stress and coping. J Pers Soc Psychol 1999; 77(5): 1087.CrossRefGoogle ScholarPubMed
Dunkley, DM, Mandel, T, Ma, D. Perfectionism, neuroticism, and daily stress reactivity and coping effectiveness 6 months and 3 years later. J Couns Psychol 2014; 61(4): 616.CrossRefGoogle ScholarPubMed
Garcia-Banda, G, Chellew, K, Fornes, J, Perez, G, Servera, M, Evans, P. Neuroticism and cortisol: pinning down an expected effect. Int J Psychophysiol 2014; 91(2): 132–8.CrossRefGoogle ScholarPubMed
Knudsen, GM, Jensen, PS, Erritzoe, D, WFC, Baaré, Ettrup, A, Fisher, PM, et al. The Center for Integrated Molecular Brain Imaging (Cimbi) database. Neuroimage 2016; 124: 1213–9.CrossRefGoogle Scholar
Costa, PT, McCrae, RR. The revised neo personality inventory (neo-pi-r). In The SAGE Handbook of Personality Theory and Assessment. 179–98. Sage, 2008.Google Scholar
Ashburner, J, Barnes, G, Chen, C, Daunizeau, J, Flandin, G, Friston, K, et al. Spm8 Manual. Functional Imaging Laboratory, Institute of Neurology, 2012.Google Scholar
Ettrup, A, Svarer, C, Mcmahon, B, Da Cunha-Bang, S, Lehel, S, Møller, K, et al. Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36: test–retest reproducibility and head-to-head comparison with the antagonist [18F]altanserin. Neuroimage 2016; 130: 167–74.CrossRefGoogle ScholarPubMed
Keller, SH, Svarer, C, Sibomana, M. Attenuation correction for the HRRT PET-scanner using transmission scatter correction and total variation regularization. IEEE Trans Med Imaging 2013; 32(9): 1611–21.CrossRefGoogle ScholarPubMed
Svarer, C, Madsen, K, Hasselbalch, SG, Pinborg, LH, Haugbøl, S, Frøkjær, VG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005; 24(4): 969–79.CrossRefGoogle Scholar
Spies, M, Nasser, A, Ozenne, B, Jensen, PS, Knudsen, GM, Fisher, PM. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels. Hum Brain Mapp 2020; 41(16): 4518–28.CrossRefGoogle ScholarPubMed
Lammertsma, AA, Hume, SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4(3 Pt 1): 153–8.CrossRefGoogle ScholarPubMed
Greve, DN, Svarer, C, Fisher, PM, Feng, L, Hansen, AE, Baare, W, et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage 2014; 92: 225–36.CrossRefGoogle ScholarPubMed
Fischl, B. Freesurfer. Neuroimage 2012; 62(2): 774–81.CrossRefGoogle ScholarPubMed
Beliveau, V, Ganz, M, Feng, L, Ozenne, B, Højgaard, L, Fisher, PM, et al. A high-resolution in vivo atlas of the human brain's serotonin system. J Neurosci 2017; 37(1): 120–8.Google ScholarPubMed
Postelnicu, G, Zollei, L, Fischl, B. Combined volumetric and surface registration. IEEE Trans Med Imaging 2009; 28(4): 508–22.CrossRefGoogle ScholarPubMed
Ichise, M, Liow, J-S, Lu, J-Q, Takano, A, Model, K, Toyama, H, et al. Carson relinearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003; 23: 1096–112.CrossRefGoogle Scholar
Diedrichsen, J. A spatially unbiased atlas template of the human cerebellum. Neuroimage 2006; 33(1): 127–38.CrossRefGoogle ScholarPubMed
Ichise, M, Ballinger, JR, Golan, H, Vines, D, Luong, A, Tsai, S, et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med 1996; 37(3): 513–20.Google ScholarPubMed
Skovdahl, HH, Mortensen, EL, Schiøtz, HK. NEO PI-R, Manual – Klinisk (1st ed). Hogrefe Psykologisk Forlag, 2011.Google Scholar
Høgsted, ES, Borgsted, C, Dam, VH, Nasser, A, Rye Jørgensen, N, Ozenne, B, et al. Stress-hormone dynamics and working memory in healthy women who use oral contraceptives versus non-users. Front Endocrinol 2021; 12: 731994.CrossRefGoogle ScholarPubMed
Fekedulegn, DB, Andrew, ME, Burchfiel, CM, Violanti, JM, Hartley, TA, Charles, LE, et al. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom Med 2007; 69(7): 651–9.CrossRefGoogle ScholarPubMed
R Core Team, . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2023.Google Scholar
Holst, KK, Budtz-Jørgensen, E. Linear latent variable models: the lava-package. Comput Stat 2013; 28(4): 1385–452.CrossRefGoogle Scholar
Whitcher, B, Schmid, V, Thornton, A. Package ‘Oro. Nifti’. Citeseer, 2013.Google Scholar
Schmitt, DP, Realo, A, Voracek, M, Allik, J. Why can't a man be more like a woman? Sex differences in Big Five personality traits across 55 cultures. J Pers Soc Psychol 2008; 94(1): 168.CrossRefGoogle Scholar
South, SC, Jarnecke, AM, Vize, CE. Sex differences in the Big Five model personality traits: a behavior genetics exploration. J Res Pers 2018; 74: 158–65.CrossRefGoogle Scholar
Soloff, PH, Price, JC, Mason, NS, Becker, C, Meltzer, CC. Gender, personality, and serotonin-2A receptor binding in healthy subjects. Psychiatry Res 2010; 181(1): 7784.CrossRefGoogle ScholarPubMed
EL, Moses-Kolko, Price, JC, Shah, N, Berga, S, Sereika, SM, Fisher, PM, et al. Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population. Neuropsychopharmacology 2011; 36(13): 2729–40.Google Scholar
Adams, KH, Pinborg, LH, Svarer, C, Hasselbalch, SG, Holm, S, Haugbøl, S, et al. A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 2004; 21(3): 1105–13.CrossRefGoogle ScholarPubMed
Frokjaer, VG, Erritzoe, D, Juul, A, Nielsen, , Holst, K, Svarer, C, et al. Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding. Psychoneuroendocrinology 2010; 35(9): 1311–20.CrossRefGoogle ScholarPubMed
Sankar, A, Ziersen, S, Ozenne, B, Dam, V, Beaman, E, Kessing, L, et al. Neocortical serotonin 2A receptor binding, neuroticism and risk of developing depression in healthy individuals. Nature Mental Health 2024; 2: 1231–8.Google Scholar
Muguruza, C, Miranda-Azpiazu, P, Díez-Alarcia, R, Morentin, B, González-Maeso, J, Callado, LF, et al. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment. Neuropharmacology 2014; 86: 311–8.CrossRefGoogle ScholarPubMed
Jakobsen, GR, Fisher, PM, Dyssegaard, A, Mcmahon, B, Holst, KK, Lehel, S, et al. Brain serotonin 4 receptor binding is associated with the cortisol awakening response. Psychoneuroendocrinology 2016; 67: 124–32.CrossRefGoogle ScholarPubMed
Frokjaer, VG, Erritzoe, D, Holst, KK, Jensen, PS, Rasmussen, PM, Fisher, PM, et al. Prefrontal serotonin transporter availability is positively associated with the cortisol awakening response. Eur Neuropsychopharmacol 2013; 23(4): 285–94.CrossRefGoogle ScholarPubMed
Conradi, J, Svensson, JE, Larsen, SV, Frokjaer, VG. Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication. PLoS One 2023; 18(8): E0290663.CrossRefGoogle ScholarPubMed
Miller, KG, Wright, AG, Peterson, LM, Kamarck, TW, Anderson, BA, Kirschbaum, C, et al. Trait positive and negative emotionality differentially associate with diurnal cortisol activity. Psychoneuroendocrinology 2016; 68: 177–85.CrossRefGoogle ScholarPubMed
Puig-Perez, S, Almela, M, Pulopulos, MM, Hidalgo, V, Salvador, A. Are neuroticism and extraversion related to morning cortisol release in healthy older people? Int J Psychophysiol 2016; 110: 243–8.CrossRefGoogle ScholarPubMed
Parsey, RV, Mann, JJ. Applications of positron emission tomography in psychiatry. Seminars in Nuclear Medicine 2003; 23(2): 129–35.CrossRefGoogle Scholar
Figure 0

Table 1 Demographic, clinical, scanner and radiotracer information

Figure 1

Figure 1 Latent variable model to estimate the association between 5-HT2AR binding and the inward facets of neuroticism.This figure shows the estimated latent variable model of the association between 5-HT2AR binding and the inward facets of neuroticism. The ellipse represents the latent variable capturing Inward-NeuroticismLV. Circular dashed lines represent error estimates included in the model. λ represents the loading of a given neuroticism sub-facet estimate onto its respective latent variable. Both Inward-NeuroticismLV and neocortex BPND were adjusted for age and gender, and neocortex BPND was additionally adjusted for magnetic resonance (MR) scanner type. Self-cons, self-consciousness; BPND, non-displaceable binding potential.

Figure 2

Figure 2 Visualisation of the distribution of cortical 5-HT2AR and associations with the inward facets of neuroticism. (a) The regional association between 5-HT2AR binding with the latent estimates of inward neuroticism in the cortex. The maps are thresholded at P = 0.05. The colour-bar represents the range of estimate values. (b) The distribution of 5-HT2AR in the cortex (reproduced with permission from Beliveau et al28).

Submit a response

eLetters

No eLetters have been published for this article.